Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Feasibility of Early Infant Diagnosis of HIV in Resource-Limited Settings: The ANRS 12140-PEDIACAM Study in Cameroon</title><author><name sortKey="Tejiokem, Mathurin C" sort="Tejiokem, Mathurin C" uniqKey="Tejiokem M" first="Mathurin C." last="Tejiokem">Mathurin C. Tejiokem</name><affiliation><nlm:aff id="aff1"><addr-line>Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff2"><addr-line>Université de Paris Sud 11, Paris, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Faye, Albert" sort="Faye, Albert" uniqKey="Faye A" first="Albert" last="Faye">Albert Faye</name><affiliation><nlm:aff id="aff3"><addr-line>Assistance Publique des Hôpitaux de Paris, Service de Pédiatrie Générale, Hôpital Robert Debré, Paris, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff4"><addr-line>Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Penda, Ida C" sort="Penda, Ida C" uniqKey="Penda I" first="Ida C." last="Penda">Ida C. Penda</name><affiliation><nlm:aff id="aff5"><addr-line>Hôpital Laquintinie, Douala, Cameroun</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff6"><addr-line>Université de Douala, Douala, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Guemkam, Georgette" sort="Guemkam, Georgette" uniqKey="Guemkam G" first="Georgette" last="Guemkam">Georgette Guemkam</name><affiliation><nlm:aff id="aff7"><addr-line>Centre Mère et Enfant de la Fondation Chantal Biya, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Ateba Ndongo, Francis" sort="Ateba Ndongo, Francis" uniqKey="Ateba Ndongo F" first="Francis" last="Ateba Ndongo">Francis Ateba Ndongo</name><affiliation><nlm:aff id="aff7"><addr-line>Centre Mère et Enfant de la Fondation Chantal Biya, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Chewa, Gisele" sort="Chewa, Gisele" uniqKey="Chewa G" first="Gisèle" last="Chewa">Gisèle Chewa</name><affiliation><nlm:aff id="aff8"><addr-line>Centre Hospitalier d'Essos, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Rekacewicz, Claire" sort="Rekacewicz, Claire" uniqKey="Rekacewicz C" first="Claire" last="Rekacewicz">Claire Rekacewicz</name><affiliation><nlm:aff id="aff9"><addr-line>Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Paris, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Rousset, Dominique" sort="Rousset, Dominique" uniqKey="Rousset D" first="Dominique" last="Rousset">Dominique Rousset</name><affiliation><nlm:aff id="aff1"><addr-line>Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff10"><addr-line>Institut Pasteur de Paris, Paris, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Kfutwah, Anfumbom" sort="Kfutwah, Anfumbom" uniqKey="Kfutwah A" first="Anfumbom" last="Kfutwah">Anfumbom Kfutwah</name><affiliation><nlm:aff id="aff1"><addr-line>Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Boisier, Pascal" sort="Boisier, Pascal" uniqKey="Boisier P" first="Pascal" last="Boisier">Pascal Boisier</name><affiliation><nlm:aff id="aff1"><addr-line>Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Warszawski, Josiane" sort="Warszawski, Josiane" uniqKey="Warszawski J" first="Josiane" last="Warszawski">Josiane Warszawski</name><affiliation><nlm:aff id="aff2"><addr-line>Université de Paris Sud 11, Paris, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff11"><addr-line>Assistance Publique des Hôpitaux de Paris, Service d'Epidémiologie et de Santé Publique, Hôpital de Bicêtre, Paris, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff12"><addr-line>Equipe 4 (VIH et IST) - INSERM U1018 (CESP), Paris, France</addr-line></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">21818273</idno><idno type="pmc">3139572</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139572</idno><idno type="RBID">PMC:3139572</idno><idno type="doi">10.1371/journal.pone.0021840</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">002B69</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002B69</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Feasibility of Early Infant Diagnosis of HIV in Resource-Limited Settings: The ANRS 12140-PEDIACAM Study in Cameroon</title><author><name sortKey="Tejiokem, Mathurin C" sort="Tejiokem, Mathurin C" uniqKey="Tejiokem M" first="Mathurin C." last="Tejiokem">Mathurin C. Tejiokem</name><affiliation><nlm:aff id="aff1"><addr-line>Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff2"><addr-line>Université de Paris Sud 11, Paris, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Faye, Albert" sort="Faye, Albert" uniqKey="Faye A" first="Albert" last="Faye">Albert Faye</name><affiliation><nlm:aff id="aff3"><addr-line>Assistance Publique des Hôpitaux de Paris, Service de Pédiatrie Générale, Hôpital Robert Debré, Paris, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff4"><addr-line>Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Penda, Ida C" sort="Penda, Ida C" uniqKey="Penda I" first="Ida C." last="Penda">Ida C. Penda</name><affiliation><nlm:aff id="aff5"><addr-line>Hôpital Laquintinie, Douala, Cameroun</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff6"><addr-line>Université de Douala, Douala, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Guemkam, Georgette" sort="Guemkam, Georgette" uniqKey="Guemkam G" first="Georgette" last="Guemkam">Georgette Guemkam</name><affiliation><nlm:aff id="aff7"><addr-line>Centre Mère et Enfant de la Fondation Chantal Biya, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Ateba Ndongo, Francis" sort="Ateba Ndongo, Francis" uniqKey="Ateba Ndongo F" first="Francis" last="Ateba Ndongo">Francis Ateba Ndongo</name><affiliation><nlm:aff id="aff7"><addr-line>Centre Mère et Enfant de la Fondation Chantal Biya, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Chewa, Gisele" sort="Chewa, Gisele" uniqKey="Chewa G" first="Gisèle" last="Chewa">Gisèle Chewa</name><affiliation><nlm:aff id="aff8"><addr-line>Centre Hospitalier d'Essos, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Rekacewicz, Claire" sort="Rekacewicz, Claire" uniqKey="Rekacewicz C" first="Claire" last="Rekacewicz">Claire Rekacewicz</name><affiliation><nlm:aff id="aff9"><addr-line>Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Paris, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Rousset, Dominique" sort="Rousset, Dominique" uniqKey="Rousset D" first="Dominique" last="Rousset">Dominique Rousset</name><affiliation><nlm:aff id="aff1"><addr-line>Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff10"><addr-line>Institut Pasteur de Paris, Paris, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Kfutwah, Anfumbom" sort="Kfutwah, Anfumbom" uniqKey="Kfutwah A" first="Anfumbom" last="Kfutwah">Anfumbom Kfutwah</name><affiliation><nlm:aff id="aff1"><addr-line>Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Boisier, Pascal" sort="Boisier, Pascal" uniqKey="Boisier P" first="Pascal" last="Boisier">Pascal Boisier</name><affiliation><nlm:aff id="aff1"><addr-line>Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroun</addr-line></nlm:aff></affiliation></author><author><name sortKey="Warszawski, Josiane" sort="Warszawski, Josiane" uniqKey="Warszawski J" first="Josiane" last="Warszawski">Josiane Warszawski</name><affiliation><nlm:aff id="aff2"><addr-line>Université de Paris Sud 11, Paris, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff11"><addr-line>Assistance Publique des Hôpitaux de Paris, Service d'Epidémiologie et de Santé Publique, Hôpital de Bicêtre, Paris, France</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="aff12"><addr-line>Equipe 4 (VIH et IST) - INSERM U1018 (CESP), Paris, France</addr-line></nlm:aff></affiliation></author></analytic><series><title level="j">PLoS ONE</title><idno type="eISSN">1932-6203</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>Early infant diagnosis (EID) of HIV is a key-point for the implementation of early HAART, associated with lower mortality in HIV-infected infants. We evaluated the EID process of HIV according to national recommendations, in urban areas of Cameroon.</p></sec><sec><title>Methods/Findings</title><p>The ANRS12140-Pediacam study is a multisite cohort in which infants born to HIV-infected mothers were included before the 8<sup>th</sup> day of life and followed. Collection of samples for HIV DNA/RNA-PCR was planned at 6 weeks together with routine vaccination. The HIV test result was expected to be available at 10 weeks. A positive or indeterminate test result was confirmed by a second test on a different sample. Systematic HAART was offered to HIV-infected infants identified. The EID process was considered complete if infants were tested and HIV results provided to mothers/family before 7 months of age. During 2007–2009, 1587 mother-infant pairs were included in three referral hospitals; most infants (n = 1423, 89.7%) were tested for HIV, at a median age of 1.5 months (IQR, 1.4–1.6). Among them, 51 (3.6%) were HIV-infected. Overall, 1331 (83.9%) completed the process by returning for the result before 7 months (median age: 2.5 months (IQR, 2.4–3.0)). Incomplete process, that is test not performed, or result of test not provided or provided late to the family, was independently associated with late HIV diagnosis during pregnancy (adjusted odds ratio (aOR) = 1.8, 95%CI: 1.1 to 2.9, p = 0.01), absence of PMTCT prophylaxis (aOR = 2.4, 95%CI: 1.4 to 4.3, p = 0.002), and emergency caesarean section (aOR = 2.5, 95%CI: 1.5 to 4.3, p = 0.001).</p></sec><sec><title>Conclusions</title><p>In urban areas of Cameroon, HIV-infected women diagnosed sufficiently early during pregnancy opt to benefit from EID whatever their socio-economic, marital or disclosure status. Reduction of non optimal diagnosis process should focus on women with late HIV diagnosis during pregnancy especially if they did not receive any PMTCT, or if complications occurred at delivery.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Unaids" uniqKey="Unaids">UNAIDS</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Newell, Ml" uniqKey="Newell M">ML Newell</name></author><author><name sortKey="Coovadia, H" uniqKey="Coovadia H">H Coovadia</name></author><author><name sortKey="Cortina Borja, M" uniqKey="Cortina Borja M">M Cortina-Borja</name></author><author><name sortKey="Rollins, N" uniqKey="Rollins N">N Rollins</name></author><author><name sortKey="Gaillard, P" uniqKey="Gaillard P">P Gaillard</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Faye, A" uniqKey="Faye A">A Faye</name></author><author><name sortKey="Le Chenadec, J" uniqKey="Le Chenadec J">J Le Chenadec</name></author><author><name sortKey="Dollfus, C" uniqKey="Dollfus C">C Dollfus</name></author><author><name sortKey="Thuret, I" uniqKey="Thuret I">I Thuret</name></author><author><name sortKey="Douard, D" uniqKey="Douard D">D Douard</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Violari, A" uniqKey="Violari A">A Violari</name></author><author><name sortKey="Cotton, Mf" uniqKey="Cotton M">MF Cotton</name></author><author><name sortKey="Gibb, Dm" uniqKey="Gibb D">DM Gibb</name></author><author><name sortKey="Babiker, Ag" uniqKey="Babiker A">AG Babiker</name></author><author><name sortKey="Steyn, J" uniqKey="Steyn J">J Steyn</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chiappini, E" uniqKey="Chiappini E">E Chiappini</name></author><author><name sortKey="Galli, L" uniqKey="Galli L">L Galli</name></author><author><name sortKey="Tovo, Pa" uniqKey="Tovo P">PA Tovo</name></author><author><name sortKey="Gabiano, C" uniqKey="Gabiano C">C Gabiano</name></author><author><name sortKey="Lisi, C" uniqKey="Lisi C">C Lisi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Goetghebuer, T" uniqKey="Goetghebuer T">T Goetghebuer</name></author><author><name sortKey="Haelterman, E" uniqKey="Haelterman E">E Haelterman</name></author><author><name sortKey="Le Chenadec, J" uniqKey="Le Chenadec J">J Le Chenadec</name></author><author><name sortKey="Dollfus, C" uniqKey="Dollfus C">C Dollfus</name></author><author><name sortKey="Gibb, D" uniqKey="Gibb D">D Gibb</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Creek, Tl" uniqKey="Creek T">TL Creek</name></author><author><name sortKey="Sherman, Gg" uniqKey="Sherman G">GG Sherman</name></author><author><name sortKey="Nkengasong, J" uniqKey="Nkengasong J">J Nkengasong</name></author><author><name sortKey="Lu, L" uniqKey="Lu L">L Lu</name></author><author><name sortKey="Finkbeiner, T" uniqKey="Finkbeiner T">T Finkbeiner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Creek, T" uniqKey="Creek T">T Creek</name></author><author><name sortKey="Tanuri, A" uniqKey="Tanuri A">A Tanuri</name></author><author><name sortKey="Smith, M" uniqKey="Smith M">M Smith</name></author><author><name sortKey="Seipone, K" uniqKey="Seipone K">K Seipone</name></author><author><name sortKey="Smit, M" uniqKey="Smit M">M Smit</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Nyandiko, Wm" uniqKey="Nyandiko W">WM Nyandiko</name></author><author><name sortKey="Otieno Nyunya, B" uniqKey="Otieno Nyunya B">B Otieno-Nyunya</name></author><author><name sortKey="Musick, B" uniqKey="Musick B">B Musick</name></author><author><name sortKey="Bucher Yiannoutsos, S" uniqKey="Bucher Yiannoutsos S">S Bucher-Yiannoutsos</name></author><author><name sortKey="Akhaabi, P" uniqKey="Akhaabi P">P Akhaabi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ioannidis, J" uniqKey="Ioannidis J">J Ioannidis</name></author><author><name sortKey="Taha, T" uniqKey="Taha T">T Taha</name></author><author><name sortKey="Kumwenda, N" uniqKey="Kumwenda N">N Kumwenda</name></author><author><name sortKey="Broadhead, R" uniqKey="Broadhead R">R Broadhead</name></author><author><name sortKey="Mtimavalye, L" uniqKey="Mtimavalye L">L Mtimavalye</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Manzi, M" uniqKey="Manzi M">M Manzi</name></author><author><name sortKey="Zachariah, R" uniqKey="Zachariah R">R Zachariah</name></author><author><name sortKey="Teck, R" uniqKey="Teck R">R Teck</name></author><author><name sortKey="Buhendwa, L" uniqKey="Buhendwa L">L Buhendwa</name></author><author><name sortKey="Kazima, J" uniqKey="Kazima J">J Kazima</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jones, Sa" uniqKey="Jones S">SA Jones</name></author><author><name sortKey="Sherman, Gg" uniqKey="Sherman G">GG Sherman</name></author><author><name sortKey="Varga, Ca" uniqKey="Varga C">CA Varga</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bwirire, Ld" uniqKey="Bwirire L">LD Bwirire</name></author><author><name sortKey="Fitzgerald, M" uniqKey="Fitzgerald M">M Fitzgerald</name></author><author><name sortKey="Zachariah, R" uniqKey="Zachariah R">R Zachariah</name></author><author><name sortKey="Chikafa, V" uniqKey="Chikafa V">V Chikafa</name></author><author><name sortKey="Massaquoi, M" uniqKey="Massaquoi M">M Massaquoi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rouet, F" uniqKey="Rouet F">F Rouet</name></author><author><name sortKey="Ekouevi, Dk" uniqKey="Ekouevi D">DK Ekouevi</name></author><author><name sortKey="Chaix, Ml" uniqKey="Chaix M">ML Chaix</name></author><author><name sortKey="Burgard, M" uniqKey="Burgard M">M Burgard</name></author><author><name sortKey="Inwoley, A" uniqKey="Inwoley A">A Inwoley</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sherman, Gg" uniqKey="Sherman G">GG Sherman</name></author><author><name sortKey="Cooper, Pa" uniqKey="Cooper P">PA Cooper</name></author><author><name sortKey="Coovadia, Ah" uniqKey="Coovadia A">AH Coovadia</name></author><author><name sortKey="Puren, Aj" uniqKey="Puren A">AJ Puren</name></author><author><name sortKey="Jones, Sa" uniqKey="Jones S">SA Jones</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ahoua, L" uniqKey="Ahoua L">L Ahoua</name></author><author><name sortKey="Ayikoru, H" uniqKey="Ayikoru H">H Ayikoru</name></author><author><name sortKey="Gnauck, K" uniqKey="Gnauck K">K Gnauck</name></author><author><name sortKey="Odaru, G" uniqKey="Odaru G">G Odaru</name></author><author><name sortKey="Odar, E" uniqKey="Odar E">E Odar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nuwagaba Biribonwoha, H" uniqKey="Nuwagaba Biribonwoha H">H Nuwagaba-Biribonwoha</name></author><author><name sortKey="Werq Semo, B" uniqKey="Werq Semo B">B Werq-Semo</name></author><author><name sortKey="Abdallah, A" uniqKey="Abdallah A">A Abdallah</name></author><author><name sortKey="Cunningham, A" uniqKey="Cunningham A">A Cunningham</name></author><author><name sortKey="Gamaliel, Jg" uniqKey="Gamaliel J">JG Gamaliel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rollins, N" uniqKey="Rollins N">N Rollins</name></author><author><name sortKey="Mzolo, S" uniqKey="Mzolo S">S Mzolo</name></author><author><name sortKey="Moodley, T" uniqKey="Moodley T">T Moodley</name></author><author><name sortKey="Esterhuizen, T" uniqKey="Esterhuizen T">T Esterhuizen</name></author><author><name sortKey="Van Rooyen, H" uniqKey="Van Rooyen H">H van Rooyen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lanoy, E" uniqKey="Lanoy E">E Lanoy</name></author><author><name sortKey="Mary Krause, M" uniqKey="Mary Krause M">M Mary-Krause</name></author><author><name sortKey="Tattevin, P" uniqKey="Tattevin P">P Tattevin</name></author><author><name sortKey="Dray Spira, R" uniqKey="Dray Spira R">R Dray-Spira</name></author><author><name sortKey="Duvivier, C" uniqKey="Duvivier C">C Duvivier</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kaplan, R" uniqKey="Kaplan R">R Kaplan</name></author><author><name sortKey="Orrell, C" uniqKey="Orrell C">C Orrell</name></author><author><name sortKey="Zwane, E" uniqKey="Zwane E">E Zwane</name></author><author><name sortKey="Bekker, Lg" uniqKey="Bekker L">LG Bekker</name></author><author><name sortKey="Wood, R" uniqKey="Wood R">R Wood</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mccoy, D" uniqKey="Mccoy D">D McCoy</name></author><author><name sortKey="Besser, M" uniqKey="Besser M">M Besser</name></author><author><name sortKey="Visser, R" uniqKey="Visser R">R Visser</name></author><author><name sortKey="Doherty, T" uniqKey="Doherty T">T Doherty</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tejiokem, Mc" uniqKey="Tejiokem M">MC Tejiokem</name></author><author><name sortKey="Nerrienet, E" uniqKey="Nerrienet E">E Nerrienet</name></author><author><name sortKey="Tene, G" uniqKey="Tene G">G Tene</name></author><author><name sortKey="Menu, E" uniqKey="Menu E">E Menu</name></author><author><name sortKey="Barre Sinoussi, F" uniqKey="Barre Sinoussi F">F Barre-Sinoussi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tchendjou, P" uniqKey="Tchendjou P">P Tchendjou</name></author><author><name sortKey="Same Ekobo, C" uniqKey="Same Ekobo C">C Same-Ekobo</name></author><author><name sortKey="Nga, A" uniqKey="Nga A">A Nga</name></author><author><name sortKey="Tejiokem, M" uniqKey="Tejiokem M">M Tejiokem</name></author><author><name sortKey="Kfutwah, A" uniqKey="Kfutwah A">A Kfutwah</name></author></analytic></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21818273</article-id><article-id pub-id-type="pmc">3139572</article-id><article-id pub-id-type="publisher-id">PONE-D-11-01957</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0021840</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Disease Diagnosis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Diagnostic Medicine</subject></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Infectious Disease Epidemiology</subject></subj-group></subj-group><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Sexually Transmitted Diseases</subject><subj-group><subject>AIDS</subject></subj-group></subj-group><subj-group><subject>Viral Diseases</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV diagnosis and management</subject><subject>HIV epidemiology</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Public Health</subject><subj-group><subject>Child Health</subject><subject>Health Screening</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Feasibility of Early Infant Diagnosis of HIV in Resource-Limited Settings: The ANRS 12140-PEDIACAM Study in Cameroon</article-title><alt-title alt-title-type="running-head">Feasibility of Early Infant Diagnosis of HIV</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tejiokem</surname><given-names>Mathurin C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Faye</surname><given-names>Albert</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Penda</surname><given-names>Ida C.</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Guemkam</surname><given-names>Georgette</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ateba Ndongo</surname><given-names>Francis</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chewa</surname><given-names>Gisèle</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rekacewicz</surname><given-names>Claire</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rousset</surname><given-names>Dominique</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff10"><sup>10</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kfutwah</surname><given-names>Anfumbom</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Boisier</surname><given-names>Pascal</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Warszawski</surname><given-names>Josiane</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff11"><sup>11</sup></xref><xref ref-type="aff" rid="aff12"><sup>12</sup></xref></contrib><contrib contrib-type="author"><collab>the ARNS 12140-PEDIACAM study group</collab></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroun</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Université de Paris Sud 11, Paris, France</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Assistance Publique des Hôpitaux de Paris, Service de Pédiatrie Générale, Hôpital Robert Debré, Paris, France</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris, France</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Hôpital Laquintinie, Douala, Cameroun</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Université de Douala, Douala, Cameroun</addr-line></aff><aff id="aff7"><label>7</label><addr-line>Centre Mère et Enfant de la Fondation Chantal Biya, Yaoundé, Cameroun</addr-line></aff><aff id="aff8"><label>8</label><addr-line>Centre Hospitalier d'Essos, Yaoundé, Cameroun</addr-line></aff><aff id="aff9"><label>9</label><addr-line>Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Paris, France</addr-line></aff><aff id="aff10"><label>10</label><addr-line>Institut Pasteur de Paris, Paris, France</addr-line></aff><aff id="aff11"><label>11</label><addr-line>Assistance Publique des Hôpitaux de Paris, Service d'Epidémiologie et de Santé Publique, Hôpital de Bicêtre, Paris, France</addr-line></aff><aff id="aff12"><label>12</label><addr-line>Equipe 4 (VIH et IST) - INSERM U1018 (CESP), Paris, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Myer</surname><given-names>Landon</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"></xref></contrib></contrib-group><aff id="edit1">University of Cape Town, South Africa</aff><author-notes><corresp id="cor1">* E-mail: <email>tejiokem@pasteur-yaounde.org</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: MCT AF ICP CR AK DR PB JW. Analyzed the data: MCT PB JW. Wrote the paper: MCT AF ICP GG FAN GC CR AK DR PB JW. Coordination of the study: MCT AF ICP CR DR AK PB JW. Recruitment and infants follow up: ICP GG FAN GC.</p></fn></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>19</day><month>7</month><year>2011</year></pub-date><volume>6</volume><issue>7</issue><elocation-id>e21840</elocation-id><history><date date-type="received"><day>24</day><month>1</month><year>2011</year></date><date date-type="accepted"><day>11</day><month>6</month><year>2011</year></date></history><permissions><copyright-statement>Tejiokem et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2011</copyright-year></permissions><abstract><sec><title>Background</title><p>Early infant diagnosis (EID) of HIV is a key-point for the implementation of early HAART, associated with lower mortality in HIV-infected infants. We evaluated the EID process of HIV according to national recommendations, in urban areas of Cameroon.</p></sec><sec><title>Methods/Findings</title><p>The ANRS12140-Pediacam study is a multisite cohort in which infants born to HIV-infected mothers were included before the 8<sup>th</sup> day of life and followed. Collection of samples for HIV DNA/RNA-PCR was planned at 6 weeks together with routine vaccination. The HIV test result was expected to be available at 10 weeks. A positive or indeterminate test result was confirmed by a second test on a different sample. Systematic HAART was offered to HIV-infected infants identified. The EID process was considered complete if infants were tested and HIV results provided to mothers/family before 7 months of age. During 2007–2009, 1587 mother-infant pairs were included in three referral hospitals; most infants (n = 1423, 89.7%) were tested for HIV, at a median age of 1.5 months (IQR, 1.4–1.6). Among them, 51 (3.6%) were HIV-infected. Overall, 1331 (83.9%) completed the process by returning for the result before 7 months (median age: 2.5 months (IQR, 2.4–3.0)). Incomplete process, that is test not performed, or result of test not provided or provided late to the family, was independently associated with late HIV diagnosis during pregnancy (adjusted odds ratio (aOR) = 1.8, 95%CI: 1.1 to 2.9, p = 0.01), absence of PMTCT prophylaxis (aOR = 2.4, 95%CI: 1.4 to 4.3, p = 0.002), and emergency caesarean section (aOR = 2.5, 95%CI: 1.5 to 4.3, p = 0.001).</p></sec><sec><title>Conclusions</title><p>In urban areas of Cameroon, HIV-infected women diagnosed sufficiently early during pregnancy opt to benefit from EID whatever their socio-economic, marital or disclosure status. Reduction of non optimal diagnosis process should focus on women with late HIV diagnosis during pregnancy especially if they did not receive any PMTCT, or if complications occurred at delivery.</p></sec></abstract><counts><page-count count="7"></page-count></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>By the end of 2009, an estimated 2.5 million children worldwide were living with HIV, mostly a consequence of vertical transmission, and more than 90% of these children are in sub-Saharan Africa <xref ref-type="bibr" rid="pone.0021840-UNAIDS1">[1]</xref>. In resource limited countries, about 35% of HIV infected infants without any therapeutic intervention die before the age of one year <xref ref-type="bibr" rid="pone.0021840-Newell1">[2]</xref>. Observational studies in industrialized countries and a randomized clinical trial in South Africa demonstrated that early initiation of HAART in infants dramatically reduces morbidity and mortality <xref ref-type="bibr" rid="pone.0021840-Faye1">[3]</xref>–<xref ref-type="bibr" rid="pone.0021840-Goetghebuer1">[6]</xref>. These results led the World Health Organization (WHO), in 2008, to recommend systematic early initiation of HAART to all HIV-infected infants diagnosed within the first year of life, and since 2010, within the first two years of life, irrespective of CD4 count or WHO clinical stage <xref ref-type="bibr" rid="pone.0021840-World1">[7]</xref>, <xref ref-type="bibr" rid="pone.0021840-World2">[8]</xref>. Thus, early diagnosis of HIV infection in infants is essential. In 2008, only 15% of HIV-exposed infants benefited from recommended virological tests within the first two months of life <xref ref-type="bibr" rid="pone.0021840-World3">[9]</xref>.</p><p>Many sub-Saharan African countries are increasingly developing and scaling up access to early infant HIV virological testing, particularly using dried blood spots (DBS) <xref ref-type="bibr" rid="pone.0021840-World3">[9]</xref>, <xref ref-type="bibr" rid="pone.0021840-Creek1">[10]</xref>, <xref ref-type="bibr" rid="pone.0021840-Creek2">[11]</xref> generally collected in clinical sites and sent to reference laboratories. In Cameroon a pilot program of HIV early infant diagnosis, was launched in 2007 using DBS with clinical sites collecting and sending samples to two referral laboratories for testing. The main difficulties encountered were the long delay between blood collection and the result, the large proportion of parents who failed to return for their infants' results and HIV-infected infants being lost to follow-up <xref ref-type="bibr" rid="pone.0021840-Ministre1">[12]</xref>. Several studies on PMTCT programs and clinical cohorts throughout sub-Saharan Africa similarly experienced high rates of loss to follow up <xref ref-type="bibr" rid="pone.0021840-Nyandiko1">[13]</xref>–<xref ref-type="bibr" rid="pone.0021840-Manzi1">[15]</xref> and some identified poor socioeconomic conditions as being a cause <xref ref-type="bibr" rid="pone.0021840-Ioannidis1">[14]</xref>, <xref ref-type="bibr" rid="pone.0021840-Jones1">[16]</xref>, <xref ref-type="bibr" rid="pone.0021840-Bwirire1">[17]</xref>. Despite the investment of financial and human resources, it remains of primary importance to improve the acceptability of early HIV testing in infants.</p><p>The ANRS 12140-PEDIACAM study started in Cameroon in November 2007 with two main objectives: to study the feasibility and effectiveness, in routine practice, of early antiretroviral multitherapy offered systematically to HIV-infected infants before 7 months of age; and to evaluate the humoral response of these children to vaccines of the Expanded Program of Immunization (EPI). All infants born to HIV-infected mothers included in the Pediacam study were offered early infant diagnosis (EID). Here, we describe the complete EID process (HIV test performed and results provided to mothers/family before 7 months of age) in urban areas of Cameroon and identify maternal and infant characteristics associated with the EID process being incomplete.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>The ANRS 12140-Pediacam survey</title><p>Pediacam is an ongoing prospective observational cohort coordinated at the Centre Pasteur of Cameroon, and conducted in three referral hospitals in the two largest cities of Cameroon: the Central Hospital Maternity (CHM)/Mother and Child Center of the Chantal Biya Foundation (MCC-CBF), the Hospital Center Essos (HCE) both in Yaounde and Laquintinie Hospital (LH) in Douala. These referral hospitals are among the pioneers in the fight against HIV infection in Cameroon and offer a full range of services for infant and adult health needs in their areas. The Pediacam study comprises two consecutive phases. All infants born live to HIV-infected mothers with documented serostatus were included before the 8<sup>th</sup> day of life in the first phase of the study, and were followed, tested for HIV and given routine vaccinations by nurses according to the Cameroonian Expanded Program on Immunization schedule: BCG and oral polio vaccine at birth, combination diphtheria, tetanus, pertussis, hepatitis B vaccine and <italic>Haemophilus influenzae</italic> type b (Hib) vaccine, oral polio vaccine at 6, 10 and 14 weeks. Prior to inclusion, mothers were provided, by the physicians involved in the study, with information about the study, the benefits of follow up and infant testing at 6 weeks, and were invited to give written informed consent for the participation of their infant in the study. During the first visit planned at 6 weeks, early HIV diagnosis was proposed after counselling in addition to the routine clinical, nutritional and immunization follow up. In the second phase, systematic HAART and follow up was offered to all HIV-infected children included in the first phase, and also to HIV-infected children not followed since birth but aged less than 7 months at diagnosis of HIV infection. Infants born to HIV-uninfected mothers were also included in a control group. The ANRS-Pediacam study was granted ethical approval in Cameroon by the National Ethics Committee and in France by the Biomedical Research Committee of the Pasteur Institute of Paris. The Cameroon Ministry of Public Health gave administrative authorization to start the study.</p></sec><sec id="s2b"><title>Study population</title><p>This analysis included all infants born live to HIV-infected mothers enrolled into the first phase of Pediacam from November 2007 to December 2009. They were all aged at least six months at the time of this analysis.</p></sec><sec id="s2c"><title>Process of early infant diagnosis of HIV</title><p>Infant follow-up was scheduled to coincide with the Cameroon National EPI timetable at 6, 10 and 14 weeks thereby limiting the number of hospital visits. Samples for HIV virological testing were collected from HIV-exposed infants at the first follow-up visit planned at 6 weeks of age and the results were expected to be available at the next visit planned at 10 weeks. The study physicians and psychosocial workers contributed to post-test counselling. A positive or indeterminate test result was confirmed by a second test on a different sample collected as soon as possible after a phone call to the parents. A second test was also planned for breastfed infants, six weeks after weaning. In the Pediacam study, information concerning infant feeding was reported orally by mothers at inclusion i.e. before the 8<sup>th</sup> day of life and during the first phase follow up visits at 6, 10 and 14 weeks. The central coordinating team regularly identified infants who did not return for a follow-up visit within one week of the planned date and organised with the clinical site to make reminder phone calls. Incentives, including free medical support for consultation, HIV diagnosis, additional vaccine (<italic>Haemophilus influenzae</italic> type b which was not included in the Expanded Program on Immunization at the time this project was launched), and reimbursement of taxi fares were provided to participants by the Pediacam study during follow-up visits. The project provided free milk as required to women who choose formula feeding. For infants who tested HIV negative but were not included in the second phase of the Pediacam study, clinical follow up was encouraged until at least the HIV serological test at 15–18 months, in line with the national recommendations. The EID process from birth to the announcement of the result to the family was considered to be “complete” if the HIV virological test was performed and the result provided to mothers/family before 7 months of age.</p></sec><sec id="s2d"><title>Virological determination of HIV status</title><p>At the first follow-up visit for HIV-exposed infants attending the Yaoundé sites, whole blood was collected into EDTA-containing anticoagulant tubes and transferred to the Virology Laboratory of Centre Pasteur of Cameroon. The samples were tested for HIV RNA by a real-time polymerase chain reaction (RT PCR) (Biocentric HIV Charge Virale) using the TaqMan technology in an in-house protocol validated by the French National Agency for Research on AIDS and Viral Hepatitis <xref ref-type="bibr" rid="pone.0021840-Rouet1">[18]</xref>. Samples from infants attending the Douala site were collected onto filter papers (DBS), processed according to standard procedures <xref ref-type="bibr" rid="pone.0021840-Sherman1">[19]</xref> and transported to the National Program Reference laboratory, managed by the US Center for Disease Control at Mutengene. To reduce the delay between blood collection and availability of the test result at the collection site, one of the DBS collected from each infant at the Douala site was also sent to the Virology Laboratory of Centre Pasteur of Cameroon. Biocentric HIV DNA cell kit was used to test for HIV proviral DNA. All samples were also subjected to an in-house serotyping assay to distinguish between HIV groups and indirectly confirmed maternal HIV serological status.</p></sec><sec id="s2e"><title>Data collection</title><p>Data concerning socio-demographic and obstetrical characteristics, strategies for prevention of mother-to-child transmission, neonatal anthropometric and clinical characteristics, postnatal treatment, feeding option, and routine immunization were collected in standardized questionnaires for each mother-child pair included. Clinical, vaccination and nutrition status was evaluated at each visit.</p></sec><sec id="s2f"><title>Statistical analysis</title><p>Characteristics of mother-infant pairs were described using medians with interquartile ranges (IQR) for continuous variables and percentages with frequencies for categorical variables. Each step of the EID process was described, and proportions were estimated with 95% confidence intervals (95%CI). For multiple births, only one infant, randomly selected was included in the statistical analysis. Univariate and multivariate logistic regressions were performed to identify factors associated with “incomplete EID process”.</p><p>A first multivariate logistic regression model included non collinear variables associated with “incomplete EID process” (as dependant variable) if the p-value was ≤0.2 in the univariate analysis. The final model was obtained using a backward-stepwise strategy with consideration for confounding effects and interactions. We systematically included the study site and the mother's education level. Statistical analyses were performed using STATA version 10.0 (Stata Corp, College Station, TX, USA). A p-value of 5% was considered for statistical significance of association.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Baseline characteristics of the study population</title><p>Between November 2007 and December 2009, 1645 infants born to 1587 HIV infected mothers at three referral hospitals were included in the ANRS 12140-Pediacam study: 756 (45.9%) at the CH/MCC-CBF; 406 (24.7%) at the HCE in Yaoundé and 483 (29.4%) at the LH in Douala. Before pregnancy, 666 (42.0%) of the 1587 mothers were aware of their HIV infection. The median age of mothers at delivery was 29.2 years (IQR, 25.8–32.8). Among the mothers, 89.2% delivered vaginally, 3.5% had multiple births (52 twins and four triplets; one infant each died at delivery in the case of two twins), 9.9% did not take any prophylaxis for PMTCT, and 10.7% declared breastfeeding exclusively. Of the mother-infant pairs enrolled, 1176 (74.1%) mothers delivered in maternities participating in the study, 392 (24.7%) in other maternities, most of which were located in the same cities as the referral hospitals, and 19 (1.2%) at home or on their way to health facilities to deliver. The median age at enrolment of the HIV-exposed infants was 3 days (IQR, 1–5) and 51.8% were male. The median birth weight was 3150 g (IQR, 2800–3500).</p></sec><sec id="s3b"><title>Early infant diagnosis process</title><p>Of the 1587 mother-infant pairs, 90.2% (1431) attended at least one scheduled follow-up visit. Only 0.6% (8) of the infants were not tested, although the mothers agreed to HIV testing during the consultation. The mothers of 94.9% (1351) of 1423 infants tested returned to collect the result: 75.3% (1018) received the result at or before the infant was 3 months old; 23.2% (313) between ages 4 and 6 months; and only 1.5% (20) were tested and learned about their HIV result after 6 months of age. The median age at HIV testing was 1.5 months (IQR, 1.4–1.6), with no significant differences observed between the sites, and at delivery of the result was 2.5 months (IQR, 2.4–3.0). The median time between HIV testing and receipt of the test result was 1.1 month (IQR, 1.0–1.2) with statistically significant difference according to site of inclusion (1.0 month for CH/MCC-CBF, 1.0 month for HCE and 1.5 month for LH ; p<10<sup>−3</sup>). HIV infection was diagnosed in 3.7% (95%CI: 2.8–4.8, n = 50) of infants whose family returned to collect result. Of the 5.1% (n = 72) of infants whose parents did not return to learn about their HIV result, only one had a positive HIV PCR result, and had died before the test result could be returned.</p><p>Overall, the EID process was incomplete for 16.1% (95%CI: 14.4–18.0; n = 256) of the 1587 HIV-exposed infants: these infants were either not tested or their families did not return to collect the HIV results before 7 months of age (<xref ref-type="fig" rid="pone-0021840-g001">Fig. 1</xref>). The vital status of infants who did not return for a follow-up visit was determined by phone calls in 87 cases: 25 died before HIV testing or collection of results, including 14 deaths before the first visit scheduled before 7 weeks of age. Of the parents of the 62 remaining infants, 45 gave various reasons to justify their failure to attend the follow up or to collect the HIV result. Over half (57.8%) reported moving and in 11.1%, the mothers were sick. Other reasons included refusal of HIV testing, fear of the HIV test results, forgetting about the follow up visit, the time required for the consultation, attending follow up in another health structure, and death of a parent. For 149 infants, no information could be obtained concerning the vital status because they could not be traced mostly due to missing or incorrect contact information (<xref ref-type="fig" rid="pone-0021840-g001">Fig. 1</xref>). These infants were considered to be lost to follow up.</p><fig id="pone-0021840-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0021840.g001</object-id><label>Figure 1</label><caption><title>Take-up and key points of early infant HIV diagnosis process (ANRS12140-Pediacam study, Cameroon, 2007–2009).</title></caption><graphic xlink:href="pone.0021840.g001"></graphic></fig></sec><sec id="s3c"><title>Factors associated with incomplete early infant diagnosis process</title><p>In univariate analysis, “incomplete EID process” was significantly associated with late HIV diagnosis during pregnancy (less than 3 months before delivery), few antenatal visits (less than 4 visits), absence of MTCT prophylaxis, emergency caesarean section for delivery, low mother educational level, the lack of a functional refrigerator, and non disclosure of maternal HIV status to the partner (<bold><xref ref-type="supplementary-material" rid="pone.0021840.s001">Table S1</xref></bold>). “Incomplete EID process” also tended to be more frequent among cases of premature delivery (less than 37 weeks of pregnancy, p = 0.09), multiple birth (p = 0.07) and infant hospitalisation at birth (p = 0.07).</p><p>In multivariate analysis (<xref ref-type="table" rid="pone-0021840-t001"><bold>Table 1</bold></xref>), “incomplete EID process” remained independently associated with late HIV diagnosis during pregnancy (adjusted odds ratio (aOR): 1.8; 95%CI: 1.1 to 2.9; p = 0.01), absence of MTCT prophylaxis (aOR: 2.4; 95%CI: 1.4 to 4.3; p = 0.002), and emergency caesarean section (aOR: 2.5, 95%CI: 1.5 to 4.3; p = 0.001). Multiple birth tended to be associated (aOR = 1.8, 95%CI: 0.9 to 3.7, p = 0.10). None of low mother's education level, the lack of a functional fridge, non disclosure of HIV status to partner, or few antenatal visits were associated with “incomplete EID process”.</p><table-wrap id="pone-0021840-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0021840.t001</object-id><label>Table 1</label><caption><title>Multivariate analysis: factors associated with incomplete early infant HIV diagnosis process (ANRS12140-Pediacam study, Cameroon, 2007–2009).</title></caption><alternatives><graphic id="pone-0021840-t001-1" xlink:href="pone.0021840.t001"></graphic><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"></col><col align="center" span="1"></col><col align="center" span="1"></col><col align="center" span="1"></col><col align="center" span="1"></col></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"></td><td colspan="2" align="left" rowspan="1">Initial logistic regression model</td><td colspan="2" align="left" rowspan="1">Final logisticregression model</td></tr><tr><td align="left" rowspan="1" colspan="1">Total (n = 1285)</td><td align="left" rowspan="1" colspan="1">adjusted OR (CI 95%)</td><td align="left" rowspan="1" colspan="1">p-value</td><td align="left" rowspan="1" colspan="1">adjusted OR (CI 95%)</td><td align="left" rowspan="1" colspan="1">p-value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Clinical sites</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" rowspan="1" colspan="1">EHC<xref ref-type="table-fn" rid="nt101">*</xref></td><td align="left" rowspan="1" colspan="1">1.2 (0.8–1.8)</td><td align="left" rowspan="1" colspan="1">0.44</td><td align="left" rowspan="1" colspan="1">1.2 (0.8–1.8)</td><td align="left" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" rowspan="1" colspan="1">LH<xref ref-type="table-fn" rid="nt102">†</xref></td><td align="left" rowspan="1" colspan="1">0.8 (0.5–1.2)</td><td align="left" rowspan="1" colspan="1">0.28</td><td align="left" rowspan="1" colspan="1">0.8 (0.5–1.2)</td><td align="left" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" rowspan="1" colspan="1">CHM/MCC-CBF<xref ref-type="table-fn" rid="nt103">‡</xref></td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Mothers' level of education</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.50</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" rowspan="1" colspan="1">None or primary education</td><td align="left" rowspan="1" colspan="1">1.4 (0.8–2.5)</td><td align="left" rowspan="1" colspan="1">0.24</td><td align="left" rowspan="1" colspan="1">1.5 (0.8–2.6)</td><td align="left" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">Secondary</td><td align="left" rowspan="1" colspan="1">1.2 (0.8–2.0)</td><td align="left" rowspan="1" colspan="1">0.40</td><td align="left" rowspan="1" colspan="1">1.3 (0.8–2.1)</td><td align="left" rowspan="1" colspan="1">0.29</td></tr><tr><td align="left" rowspan="1" colspan="1">Higher education</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Presence of a functional fridge at home</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">1.2 (0.8–1.6)</td><td align="left" rowspan="1" colspan="1">0.33</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Time at maternal HIV diagnosis</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.10</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Less than 3 months before delivery</td><td align="left" rowspan="1" colspan="1">1.7 (1.0–2.7)</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">1.8 (1.1–2.9)</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">More than 3 months before delivery</td><td align="left" rowspan="1" colspan="1">1.2 (0.8–1.7)</td><td align="left" rowspan="1" colspan="1">0.50</td><td align="left" rowspan="1" colspan="1">1.2 (0.8–1.8)</td><td align="left" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" rowspan="1" colspan="1">Before pregnancy</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Disclosure of maternal HIV serostatus to partner</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">1.3 (0.8–1.9)</td><td align="left" rowspan="1" colspan="1">0.27</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Maternal knowledge of the fathers' HIV status</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Did not know</td><td align="left" rowspan="1" colspan="1">1.2 (0.7–1.9)</td><td align="left" rowspan="1" colspan="1">0.47</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Negative</td><td align="left" rowspan="1" colspan="1">1.4 (0.9–2.2)</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Positive</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Number of antenatal visits</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">≤3</td><td align="left" rowspan="1" colspan="1">1.1 (0.7–1.7)</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">>3</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Mode of delivery</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">Emergency C-section</td><td align="left" rowspan="1" colspan="1">2.5 (1.4–4.3)</td><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">2.5 (1.5–4.3)</td><td align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Elective C-section</td><td align="left" rowspan="1" colspan="1">0.7 (0.2–2.2)</td><td align="left" rowspan="1" colspan="1">0.59</td><td align="left" rowspan="1" colspan="1">0.8 (0.3–2.2)</td><td align="left" rowspan="1" colspan="1">0.62</td></tr><tr><td align="left" rowspan="1" colspan="1">Vaginal</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Receipt of any ART for PMTCT</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">No prophylaxis</td><td align="left" rowspan="1" colspan="1">2.3 (1.2–4.1)</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1">2.4 (1.4–4.3)</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Short-course combined ARV</td><td align="left" rowspan="1" colspan="1">1.4 (0.9–2.1)</td><td align="left" rowspan="1" colspan="1">0.14</td><td align="left" rowspan="1" colspan="1">1.3 (0.9–2.0)</td><td align="left" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Tritherapy</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Birth weight</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><2500 g</td><td align="left" rowspan="1" colspan="1">1.3 (0.7–2.2)</td><td align="left" rowspan="1" colspan="1">0.38</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">≥2500 g</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Prematurity</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><37 weeks</td><td align="left" rowspan="1" colspan="1">1.0 (0.6–1.6)</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">≥37 weeks</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Multiple birth</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">1.5 (0.7–3.4)</td><td align="left" rowspan="1" colspan="1">0.26</td><td align="left" rowspan="1" colspan="1">1.8 (0.9–3.7)</td><td align="left" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Infant hospitalised at birth</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Yes</td><td align="left" rowspan="1" colspan="1">1.2 (0.7–1.9)</td><td align="left" rowspan="1" colspan="1">0.57</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">No</td><td align="left" rowspan="1" colspan="1">ref</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label></label><p>*EHC : Essos Hospital Center, Yaoundé.</p></fn><fn id="nt102"><label>†</label><p>LH : Laquintinie Hospital, Douala.</p></fn><fn id="nt103"><label>‡</label><p>CHM / MCC-CBF: Central Hospital Maternity / Mother and Child Center of the Chantal Biya Foundation, Yaoundé.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s4"><title>Discussion</title><p>Early infant diagnosis of HIV is one of the most important challenges in the management of paediatric HIV infection in resource limited settings. Here, we describe each step and obstacles to EID in infants included in the ANRS 12140-PEDIACAM study. This study involves a large prospective cohort mainly designed to evaluate the feasibility of early HAART for HIV-infected infants at three reference hospitals in the two main cities in Cameroon. As far as we are aware, this is one of the first large prospective studies to identify factors associated with the process of infant HIV diagnosis being incomplete in African settings where early virological testing and antiretroviral drugs are now available for infants outside of the research context.</p><p>In this study, the EID process from birth to the announcement of the result to the family was considered as complete if the HIV result was provided to the family before the infant was 7 months old. Learning the HIV status of the child after age 6 months is too late to allow early initiation of HAART, in accordance with several studies <xref ref-type="bibr" rid="pone.0021840-Faye1">[3]</xref>, <xref ref-type="bibr" rid="pone.0021840-Chiappini1">[5]</xref>. This would therefore result in a missed opportunity for HIV infected infants. Thus, the Pediacam study recommends starting treatment before age 7 months for all infants diagnosed as HIV-infected in the first phase of the study.</p><p>In the Pediacam study, 90.2% of infants returned at least once for follow up and almost all were tested for HIV. The return rate was higher than those previously reported in Malawi <xref ref-type="bibr" rid="pone.0021840-Ioannidis1">[14]</xref> and Uganda <xref ref-type="bibr" rid="pone.0021840-Ahoua1">[20]</xref> where 70% (1503/2156) and 52% (292/567) of HIV exposed infants, respectively, were brought back for follow up. However, antiretroviral drugs were not easily accessible to children at the time of these previous surveys. Our active tracing method with multiple reminder calls may also explain the higher rate of return in our study.</p><p>Overall, the EID process was complete for 83.9% (95%CI: 82.0–85.6) of infants before the age of 7 months. This rate is similar to that reported in one clinical setting in Botswana (81%; 753/930) <xref ref-type="bibr" rid="pone.0021840-Creek2">[11]</xref>, but higher than those in surveys conducted in Tanzania and in South Africa where 55% (242/441) <xref ref-type="bibr" rid="pone.0021840-NuwagabaBiribonwoha1">[21]</xref> and 65% (153/233) <xref ref-type="bibr" rid="pone.0021840-Rollins1">[22]</xref>, respectively, of parents/guardians returned to learn about the results. However, age at diagnosis in these studies was more diverse: between 1 and 17 months. In the Pediacam study, the median age at collection of the HIV result was 2.5 months (IQR, 2.4–3.0). This is satisfactory in relation to promoting very wide access to HAART before 6 months of age. Initiating HAART at 3 months, as planned in the CHER randomized trial <xref ref-type="bibr" rid="pone.0021840-Violari1">[4]</xref>, would be feasible in routine practice for 75% of the infants in such settings.</p><p>Of every 100 infants offered early testing, 10 did not return for the test and six were tested but the family did not return to collect the result before the age of 7 months (both situations being incomplete EID). We investigated factors associated with incomplete EID. Late HIV diagnosis during pregnancy and absence of prophylaxis for PMTCT were significantly and independently associated with a higher risk of “incomplete EID process”. Loss to follow up was previously reported to be associated with no PMTCT prophylaxis in a study in Uganda <xref ref-type="bibr" rid="pone.0021840-Ahoua1">[20]</xref>, and with short time between HIV infection and inclusion in a study for adults in France <xref ref-type="bibr" rid="pone.0021840-Lanoy1">[23]</xref>. Of the 157 women who did not receive any PMTCT prophylaxis in Pediacam, 65.0% were diagnosed at a median time of 3 days (IQR, 1 to 15 days) before delivery (result not showed). Such a short period does not allow the women time to cope with the result, to deal with issues around disclosure to partner and to family, and to appreciate fully the benefits of medical follow up for both her and her child <xref ref-type="bibr" rid="pone.0021840-Kaplan1">[24]</xref>.</p><p>Incomplete EID was also significantly and independently associated with emergency caesarean section. Incomplete EID also tended to be more frequent in cases of multiple birth, low birth weight and infant hospitalisation at birth. Multiple birth and caesarean section were not reported to be associated with loss to follow up in a study conducted in Malawi <xref ref-type="bibr" rid="pone.0021840-Ioannidis1">[14]</xref>. Although our finding of an association with emergency caesarean section was unexpected, there are at least two possible explanations. First, saving the life of the mother and infant is the primary concern in cases of obstetrical emergency or neonatal complications. In such situations, prevention of HIV transmission may be a lower immediate priority for the mother and the medical team, and there may be little opportunity to discuss the benefits of follow up and infant HIV testing. Second, complications of labour or delivery are likely to be one of the reasons to refer women followed in primary antenatal care setting to the hospitals participating in the Pediacam survey. These women may prefer to return after delivery to their local hospital for infant follow up. Unfortunately, the referral status of pregnant women was not collected in Pediacam study so it is not possible to test whether or not this was indeed the case.</p><p>Incomplete EID process was also associated, in univariate analysis, with factors related to living conditions and socio-economic status: low level of mother education, absence of a functional fridge at home, and failure to disclose their HIV status to partner. However, odds ratios were lower for these factors than for factors related to late HIV diagnosis and obstetrical context of delivery (<bold><xref ref-type="supplementary-material" rid="pone.0021840.s001">Table S1</xref></bold>). Moreover, these associations did not remain significant in multivariate analysis (<xref ref-type="table" rid="pone-0021840-t001"><bold>Table 1</bold></xref>). Our results thus contrast with those of other studies which report a higher rate of loss to follow up in poor socioeconomic conditions (low education level, farming, long distances and cost of transport) <xref ref-type="bibr" rid="pone.0021840-Ioannidis1">[14]</xref>, <xref ref-type="bibr" rid="pone.0021840-McCoy1">[25]</xref> and in cases of non disclosure of HIV status <xref ref-type="bibr" rid="pone.0021840-Jones1">[16]</xref>.</p><p>The median time between HIV testing and receipt of test result differed between Pediacam sites, mainly due to the DBS being used in one of the sites. More time is needed for preparation, conditioning and transport of DBS to the laboratory. This did not affect the completeness of the process within 6 months, but could do so if the aim was to complete the process in 3 months. This underlines the importance of carefully evaluating local obstacles to implementation of an EID programme.</p><p>The proportion of mothers initiating formula feeding was higher than is generally the case nationwide, but was consistent with what has been described previously in these settings <xref ref-type="bibr" rid="pone.0021840-Tejiokem1">[26]</xref>, <xref ref-type="bibr" rid="pone.0021840-Tchendjou1">[27]</xref>. In 2009, only 32% of HIV-infected mothers reported formula feeding <xref ref-type="bibr" rid="pone.0021840-Ministre1">[12]</xref>. The infant feeding policy in Cameroon promotes exclusive breastfeeding for the first six months, unless replacement feeding is acceptable, feasible, affordable, sustainable and safe. The high proportion of formula feeding in the Pediacam study may be explained by the active counselling, by the higher economic status and lower socio-cultural pressure on feeding practices in urban areas than in others areas in the country.</p><p>This study has some limitations. The inclusion of infants born to HIV-infected mothers at Pediacam study maternities was not exhaustive. The failure to return may in some cases have been the consequence of mortality. However, the vital status could not be established for 149 of the 256 children with incomplete process (<xref ref-type="fig" rid="pone-0021840-g001"><bold>Fig. 1</bold></xref>). The mortality rate during the process, estimated among the 1438 infants with known vital status, was 17.4 per 1000 live births (95%CI: 11.3–25.6, n = 25), which is lower than the estimated national rate in Cameroon: 29‰ in the first month <xref ref-type="bibr" rid="pone.0021840-Institut1">[28]</xref>. This lower rate may have been due to better early clinical management. The value, however, may also reflect a high rate of early mortality among the infants who never returned, possibly due to severe HIV infection. Indeed, continuing this argument would suggest that the transmission rate for HIV of 3.6% (2.8 – 4.8) may be an underestimation.</p><p>Despite these limitations, one of the strengths of Pediacam study was that it was conducted in three centres in two large cities of Cameroon. These centres have very different working practices and recruitments so the study reflects the diversity of practical management of EID in a heterogeneous population mostly living in urban areas.</p><p>In summary, our study shows good take-up of EID services and high proportion of mothers returning to collect their infant's result within the first six months of life in an operational setting. As nearly half of the mothers knew their HIV status before pregnancy, most of them were likely to have knowledge of the benefits of PMTCT, and infant HIV diagnosis and follow up. In the Pediacam study, the risk factors for “incomplete EID process” reflected the quality of prenatal care and the obstetrical context (late HIV diagnosis, lack of any prophylaxis for PMTCT, emergency caesarean section), rather than environmental conditions such as socio-economic, marital and disclosure status. This may be partly due to the follow-up schedule being tied to the national vaccination programme, and partly to incentives and active reminders by telephone calls.</p><p>It seems to be very important to focus on women diagnosed at, or only a few days before, delivery, especially if they did not receive any PMTCT, or if they were transferred from their usual care setting for emergency delivery. All maternity team members should be aware of these issues, so as to offer reinforced support just after delivery in these situations at risk of non optimal follow up of the infant.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0021840.s001"><label>Table S1</label><caption><p>Univariate analysis: factors associated with incomplete HIV early infant diagnosis process: (ANRS 12140-Pediacam study, Cameroon, 2007–2009).</p><p>(DOC)</p></caption><media xlink:href="pone.0021840.s001.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0021840.s002"><label>Appendix S1</label><caption><p>The ANRS 12140-Pediacam Study Team.</p><p>(DOC)</p></caption><media xlink:href="pone.0021840.s002.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We dedicate this publication to the memories of the late Dr Chantal Same Ekobo and Prof Félix Tietche, who coordinated two of our clinical sites.</p><p>We are particularly grateful to parents who accepted their children to be included in this study. We thank the entire ARNS 12140 study team <bold>(<xref ref-type="supplementary-material" rid="pone.0021840.s002">Appendix S1</xref>)</bold> at each site for their commitment and excellent collaboration. Our appreciation are also extended to institutions that contributed to the conduct of this study, including the Cameroon Ministry of Public Health, the National Ethics Committee, the Association of people living with HIV/AIDS, the Centre Pasteur of Cameroun, the Central Hospital Maternity, the Mother and Child Center of the Chantal Biya Foundation, and the Essos Hospital Center in Yaoundé, Laquintinie Hospital in Douala, and the National HIV Program reference laboratory- US Center for Disease Control at Mutengene, the Fondation Merieux and the Fondation Total.</p><p>Special thanks to Prof Françoise Barré-Sinoussi for her mentorship in the preparation and setting up of the ANRS 12140 programme.</p><p>We acknowledge the French National Agency for Research on AIDS and Viral Hepatitis for funding this study.</p></ack><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This prospective study is sponsored by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="pone.0021840-UNAIDS1"><label>1</label><element-citation publication-type="other"> <person-group person-group-type="author"><name><surname>UNAIDS</surname></name></person-group> <year>2010</year> <article-title>UNAIDS report on the global AIDS epidemic 2010.</article-title> <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2009/default.asp">http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2009/default.asp</ext-link>. Accessed 2010 December 14</comment> </element-citation></ref><ref id="pone.0021840-Newell1"><label>2</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Newell</surname><given-names>ML</given-names></name><name><surname>Coovadia</surname><given-names>H</given-names></name><name><surname>Cortina-Borja</surname><given-names>M</given-names></name><name><surname>Rollins</surname><given-names>N</given-names></name><name><surname>Gaillard</surname><given-names>P</given-names></name><etal></etal></person-group> <year>2004</year> <article-title>Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.</article-title> <source>Lancet</source> <volume>364</volume> <fpage>1236</fpage> <lpage>1243</lpage> <pub-id pub-id-type="pmid">15464184</pub-id></element-citation></ref><ref id="pone.0021840-Faye1"><label>3</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Faye</surname><given-names>A</given-names></name><name><surname>Le Chenadec</surname><given-names>J</given-names></name><name><surname>Dollfus</surname><given-names>C</given-names></name><name><surname>Thuret</surname><given-names>I</given-names></name><name><surname>Douard</surname><given-names>D</given-names></name><etal></etal></person-group> <year>2004</year> <article-title>Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1.</article-title> <source>Clin Infect Dis</source> <volume>39</volume> <fpage>1692</fpage> <lpage>1698</lpage> <pub-id pub-id-type="pmid">15578372</pub-id></element-citation></ref><ref id="pone.0021840-Violari1"><label>4</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Violari</surname><given-names>A</given-names></name><name><surname>Cotton</surname><given-names>MF</given-names></name><name><surname>Gibb</surname><given-names>DM</given-names></name><name><surname>Babiker</surname><given-names>AG</given-names></name><name><surname>Steyn</surname><given-names>J</given-names></name><etal></etal></person-group> <year>2008</year> <article-title>Early antiretroviral therapy and mortality among HIV-infected infants.</article-title> <source>N Engl J Med</source> <volume>359</volume> <fpage>2233</fpage> <lpage>2244</lpage> <pub-id pub-id-type="pmid">19020325</pub-id></element-citation></ref><ref id="pone.0021840-Chiappini1"><label>5</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Chiappini</surname><given-names>E</given-names></name><name><surname>Galli</surname><given-names>L</given-names></name><name><surname>Tovo</surname><given-names>PA</given-names></name><name><surname>Gabiano</surname><given-names>C</given-names></name><name><surname>Lisi</surname><given-names>C</given-names></name><etal></etal></person-group> <year>2009</year> <article-title>Five year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy.</article-title> <source>BMC Infect Dis</source> <volume>9</volume> <fpage>140</fpage> <pub-id pub-id-type="pmid">19709432</pub-id></element-citation></ref><ref id="pone.0021840-Goetghebuer1"><label>6</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Goetghebuer</surname><given-names>T</given-names></name><name><surname>Haelterman</surname><given-names>E</given-names></name><name><surname>Le Chenadec</surname><given-names>J</given-names></name><name><surname>Dollfus</surname><given-names>C</given-names></name><name><surname>Gibb</surname><given-names>D</given-names></name><etal></etal></person-group> <year>2009</year> <article-title>Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants.</article-title> <source>Aids</source> <volume>23</volume> <fpage>597</fpage> <lpage>604</lpage> <pub-id pub-id-type="pmid">19194272</pub-id></element-citation></ref><ref id="pone.0021840-World1"><label>7</label><element-citation publication-type="other"> <collab>World Health Organization (WHO)</collab> <year>2008</year> <article-title>Report of the WHO Technical Reference Group, Paediatric HIV/Antiretroviral Therapy and Care Guideline Group Meeting, WHO headquarters, Geneva, Switzerland, 10-11April2008.</article-title> <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/hiv/pub/paediatric/WHO_Paediatric_ART_guideline_rev_mreport_2008.pdf">http://www.who.int/hiv/pub/paediatric/WHO_Paediatric_ART_guideline_rev_mreport_2008.pdf</ext-link>. Accessed 2010 December 14</comment> </element-citation></ref><ref id="pone.0021840-World2"><label>8</label><element-citation publication-type="other"> <collab>World Health Organization (WHO)</collab> <year>2010</year> <article-title>Antiretroviral therapy for HIV infection in infants and children. Towards Universal Access. Recommendations for public health approach. 2010 revision.</article-title> <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf">http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf</ext-link>. Accessed 2010 December 2</comment> </element-citation></ref><ref id="pone.0021840-World3"><label>9</label><element-citation publication-type="other"> <collab>World Health Organization (WHO), UNICEF, UNAIDS</collab> <year>2010</year> <article-title>Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009.</article-title> <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/hiv/pub/tuapr_2009_en.pdf">http://www.who.int/hiv/pub/tuapr_2009_en.pdf</ext-link>. Accessed 2011 January 18</comment> </element-citation></ref><ref id="pone.0021840-Creek1"><label>10</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Creek</surname><given-names>TL</given-names></name><name><surname>Sherman</surname><given-names>GG</given-names></name><name><surname>Nkengasong</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Finkbeiner</surname><given-names>T</given-names></name><etal></etal></person-group> <year>2007</year> <article-title>Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences.</article-title> <source>Am J Obstet Gynecol</source> <volume>197</volume> <fpage>S64</fpage> <lpage>71</lpage> <pub-id pub-id-type="pmid">17825652</pub-id></element-citation></ref><ref id="pone.0021840-Creek2"><label>11</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Creek</surname><given-names>T</given-names></name><name><surname>Tanuri</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Seipone</surname><given-names>K</given-names></name><name><surname>Smit</surname><given-names>M</given-names></name><etal></etal></person-group> <year>2008</year> <article-title>Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission.</article-title> <source>Pediatr Infect Dis J</source> <volume>27</volume> <fpage>22</fpage> <lpage>26</lpage> <pub-id pub-id-type="pmid">18162933</pub-id></element-citation></ref><ref id="pone.0021840-Ministre1"><label>12</label><element-citation publication-type="other"> <collab>Ministère de la Santé Publique du Cameroun, Comité National de Lutte contre le SIDA</collab> <year>2009</year> <article-title>Vers l'accès universel à la prévention en faveur des groupes cibles prioritaires: prévention de la transmission du VIH de la mère à l'enfant. Rapport de progrès N°4.</article-title> <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.cnls.org/public/web/IMG/pdf/rapport_ptme_n_4.pdf">http://www.cnls.org/public/web/IMG/pdf/rapport_ptme_n_4.pdf</ext-link>. Accessed 2011 January 18</comment> </element-citation></ref><ref id="pone.0021840-Nyandiko1"><label>13</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Nyandiko</surname><given-names>WM</given-names></name><name><surname>Otieno-Nyunya</surname><given-names>B</given-names></name><name><surname>Musick</surname><given-names>B</given-names></name><name><surname>Bucher-Yiannoutsos</surname><given-names>S</given-names></name><name><surname>Akhaabi</surname><given-names>P</given-names></name><etal></etal></person-group> <year>2010</year> <article-title>Outcomes of HIV-exposed children in western Kenya: efficacy of prevention of mother to child transmission in a resource-constrained setting.</article-title> <source>J Acquir Immune Defic Syndr</source> <volume>54</volume> <fpage>42</fpage> <lpage>50</lpage> <pub-id pub-id-type="pmid">20224420</pub-id></element-citation></ref><ref id="pone.0021840-Ioannidis1"><label>14</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>J</given-names></name><name><surname>Taha</surname><given-names>T</given-names></name><name><surname>Kumwenda</surname><given-names>N</given-names></name><name><surname>Broadhead</surname><given-names>R</given-names></name><name><surname>Mtimavalye</surname><given-names>L</given-names></name><etal></etal></person-group> <year>1999</year> <article-title>Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi.</article-title> <source>Int J Epidemiol</source> <volume>28</volume> <fpage>769</fpage> <lpage>775</lpage> <pub-id pub-id-type="pmid">10480709</pub-id></element-citation></ref><ref id="pone.0021840-Manzi1"><label>15</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Manzi</surname><given-names>M</given-names></name><name><surname>Zachariah</surname><given-names>R</given-names></name><name><surname>Teck</surname><given-names>R</given-names></name><name><surname>Buhendwa</surname><given-names>L</given-names></name><name><surname>Kazima</surname><given-names>J</given-names></name><etal></etal></person-group> <year>2005</year> <article-title>High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting.</article-title> <source>Trop Med Int Health</source> <volume>10</volume> <fpage>1242</fpage> <lpage>1250</lpage> <pub-id pub-id-type="pmid">16359404</pub-id></element-citation></ref><ref id="pone.0021840-Jones1"><label>16</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Sherman</surname><given-names>GG</given-names></name><name><surname>Varga</surname><given-names>CA</given-names></name></person-group> <year>2005</year> <article-title>Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannesburg, South Africa.</article-title> <source>AIDS Care</source> <volume>17</volume> <fpage>466</fpage> <lpage>470</lpage> <pub-id pub-id-type="pmid">16036232</pub-id></element-citation></ref><ref id="pone.0021840-Bwirire1"><label>17</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Bwirire</surname><given-names>LD</given-names></name><name><surname>Fitzgerald</surname><given-names>M</given-names></name><name><surname>Zachariah</surname><given-names>R</given-names></name><name><surname>Chikafa</surname><given-names>V</given-names></name><name><surname>Massaquoi</surname><given-names>M</given-names></name><etal></etal></person-group> <year>2008</year> <article-title>Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi.</article-title> <source>Trans R Soc Trop Med Hyg</source> <volume>102</volume> <fpage>1195</fpage> <lpage>1200</lpage> <pub-id pub-id-type="pmid">18485431</pub-id></element-citation></ref><ref id="pone.0021840-Rouet1"><label>18</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Rouet</surname><given-names>F</given-names></name><name><surname>Ekouevi</surname><given-names>DK</given-names></name><name><surname>Chaix</surname><given-names>ML</given-names></name><name><surname>Burgard</surname><given-names>M</given-names></name><name><surname>Inwoley</surname><given-names>A</given-names></name><etal></etal></person-group> <year>2005</year> <article-title>Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.</article-title> <source>J Clin Microbiol</source> <volume>43</volume> <fpage>2709</fpage> <lpage>2717</lpage> <pub-id pub-id-type="pmid">15956387</pub-id></element-citation></ref><ref id="pone.0021840-Sherman1"><label>19</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Sherman</surname><given-names>GG</given-names></name><name><surname>Cooper</surname><given-names>PA</given-names></name><name><surname>Coovadia</surname><given-names>AH</given-names></name><name><surname>Puren</surname><given-names>AJ</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><etal></etal></person-group> <year>2005</year> <article-title>Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings.</article-title> <source>Pediatr Infect Dis J</source> <volume>24</volume> <fpage>993</fpage> <lpage>997</lpage> <pub-id pub-id-type="pmid">16282936</pub-id></element-citation></ref><ref id="pone.0021840-Ahoua1"><label>20</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Ahoua</surname><given-names>L</given-names></name><name><surname>Ayikoru</surname><given-names>H</given-names></name><name><surname>Gnauck</surname><given-names>K</given-names></name><name><surname>Odaru</surname><given-names>G</given-names></name><name><surname>Odar</surname><given-names>E</given-names></name><etal></etal></person-group> <year>2010</year> <article-title>Evaluation of a 5-year programme to prevent mother-to-child transmission of HIV infection in Northern Uganda.</article-title> <source>J Trop Pediatr</source> <volume>56</volume> <fpage>43</fpage> <lpage>52</lpage> <pub-id pub-id-type="pmid">19602489</pub-id></element-citation></ref><ref id="pone.0021840-NuwagabaBiribonwoha1"><label>21</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Nuwagaba-Biribonwoha</surname><given-names>H</given-names></name><name><surname>Werq-Semo</surname><given-names>B</given-names></name><name><surname>Abdallah</surname><given-names>A</given-names></name><name><surname>Cunningham</surname><given-names>A</given-names></name><name><surname>Gamaliel</surname><given-names>JG</given-names></name><etal></etal></person-group> <year>2010</year> <article-title>Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania.</article-title> <source>BMC Pediatr</source> <volume>10</volume> <fpage>44</fpage> <pub-id pub-id-type="pmid">20565786</pub-id></element-citation></ref><ref id="pone.0021840-Rollins1"><label>22</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Rollins</surname><given-names>N</given-names></name><name><surname>Mzolo</surname><given-names>S</given-names></name><name><surname>Moodley</surname><given-names>T</given-names></name><name><surname>Esterhuizen</surname><given-names>T</given-names></name><name><surname>van Rooyen</surname><given-names>H</given-names></name></person-group> <year>2009</year> <article-title>Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings.</article-title> <source>Aids</source> <volume>23</volume> <fpage>1851</fpage> <lpage>1857</lpage> <pub-id pub-id-type="pmid">19491653</pub-id></element-citation></ref><ref id="pone.0021840-Lanoy1"><label>23</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Lanoy</surname><given-names>E</given-names></name><name><surname>Mary-Krause</surname><given-names>M</given-names></name><name><surname>Tattevin</surname><given-names>P</given-names></name><name><surname>Dray-Spira</surname><given-names>R</given-names></name><name><surname>Duvivier</surname><given-names>C</given-names></name><etal></etal></person-group> <year>2006</year> <article-title>Predictors identified for losses to follow up among HIV-seropositive patients.</article-title> <source>Journal of Clinical Epidemiology</source> <volume>59</volume> <fpage>829</fpage> <lpage>835</lpage> <pub-id pub-id-type="pmid">16828676</pub-id></element-citation></ref><ref id="pone.0021840-Kaplan1"><label>24</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>R</given-names></name><name><surname>Orrell</surname><given-names>C</given-names></name><name><surname>Zwane</surname><given-names>E</given-names></name><name><surname>Bekker</surname><given-names>LG</given-names></name><name><surname>Wood</surname><given-names>R</given-names></name></person-group> <year>2008</year> <article-title>Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment.</article-title> <source>Aids</source> <volume>22</volume> <fpage>1679</fpage> <lpage>1681</lpage> <pub-id pub-id-type="pmid">18670232</pub-id></element-citation></ref><ref id="pone.0021840-McCoy1"><label>25</label><element-citation publication-type="other"> <person-group person-group-type="author"><name><surname>McCoy</surname><given-names>D</given-names></name><name><surname>Besser</surname><given-names>M</given-names></name><name><surname>Visser</surname><given-names>R</given-names></name><name><surname>Doherty</surname><given-names>T</given-names></name></person-group> <year>2002</year> <article-title>Interim findings on the National PMTCT pilot sites: Summary of lessons and recommendations. Durban: Health Systems Trust.</article-title> <comment>Available: <ext-link ext-link-type="ftp" xlink:href="ftp://ftp.hst.org.za/pubs/pmtct/pmtctsummary.pdf">ftp://ftp.hst.org.za/pubs/pmtct/pmtctsummary.pdf</ext-link>. Accessed 2011 January 18</comment> </element-citation></ref><ref id="pone.0021840-Tejiokem1"><label>26</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Tejiokem</surname><given-names>MC</given-names></name><name><surname>Nerrienet</surname><given-names>E</given-names></name><name><surname>Tene</surname><given-names>G</given-names></name><name><surname>Menu</surname><given-names>E</given-names></name><name><surname>Barre-Sinoussi</surname><given-names>F</given-names></name><etal></etal></person-group> <year>2004</year> <article-title>[Prevention of mother to child HIV-1 transmission (MTC) in Cameroon].</article-title> <source>Med Mal Infect</source> <volume>34</volume> <issue>Suppl 1</issue> <fpage>S57</fpage> <lpage>60</lpage> <pub-id pub-id-type="pmid">15676250</pub-id></element-citation></ref><ref id="pone.0021840-Tchendjou1"><label>27</label><element-citation publication-type="journal"> <person-group person-group-type="author"><name><surname>Tchendjou</surname><given-names>P</given-names></name><name><surname>Same-Ekobo</surname><given-names>C</given-names></name><name><surname>Nga</surname><given-names>A</given-names></name><name><surname>Tejiokem</surname><given-names>M</given-names></name><name><surname>Kfutwah</surname><given-names>A</given-names></name><etal></etal></person-group> <year>2010</year> <article-title>Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon.</article-title> <source>PLoS One</source> <volume>5</volume> <fpage>e10411</fpage> <pub-id pub-id-type="pmid">20454459</pub-id></element-citation></ref><ref id="pone.0021840-Institut1"><label>28</label><element-citation publication-type="other"> <collab>Institut National de la Statistique, ORC-Macro</collab> <year>2004</year> <article-title>Enquête démographique et de Santé, Cameroun.</article-title> <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.measuredhs.com/pubs/pdf/FR163/FR163-CM04.pdf">http://www.measuredhs.com/pubs/pdf/FR163/FR163-CM04.pdf</ext-link>. Accessed 2011 January 18</comment> </element-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B69 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002B69 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.32. |  |